On the Frontlines of Non-Small Cell Lung Cancer
Stay current on the latest developments in the field with On the Frontlines of Non-Small Cell Lung Cancer, an exclusive podcast series featuring expert perspectives on emerging data, evolving treatment approaches, and other key considerations.
Zidesamtinib for ROS1-Positive Non-Small Cell Lung Cancer
On the Frontlines of Non-Small Cell Lung CancerZidesamtinib for ROS1-Positive Non-Small Cell Lung Cancer
Ryan Quigley
Alexander Drilon, MD
Molecular Testing in Advanced Non-Small Cell Lung Cancer
On the Frontlines of Non-Small Cell Lung CancerMolecular Testing in Advanced Non-Small Cell Lung Cancer
Alexandria May, PharmD, BCPS
Timothy F. Burns, MD, PhD
Novel Immune Checkpoint Strategies in Non-Small Cell Lung Cancer Care
Project Oncology®Novel Immune Checkpoint Strategies in Non-Small Cell Lung Cancer Care
Jacob Sands, MD
Aakesh Desai, MD, MPH
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Project Oncology®NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Jacob Sands, MD
Liza Villaruz, MD
- advertisement